Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Neuralgia, Pain, Pain in extremity, Thrombocytopenia, Urine analysis
Clinical narrative: numbness in whole body; thromboembolic events with thrombocytopenia; thromboembolic events with thrombocytopenia; full feeling in head; dizzy; vision trouble; trouble with balance; Vertigo; Severe hand pain; nerve pain/severe neuropathic pain - all of body burning in my nerves; sevely burned; Exvrutiating pain; overly sore muscles; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in arm left, administration date 28Aug2021 10:00 (Lot number: FD8448) at the age of 47 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Mental health issue", start date: 15Jun1989 (ongoing), notes: Pertinent details: Counselors Psychiatrists, meds.; "TMJ", start date: 15Jun1991 (ongoing), notes: Pertinent details: Dental Exam.; "Essential tremor", start date: 15Jun2013 (ongoing). Prior vaccination (within 4 weeks) was none. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1; Batch/Lot number: FC3180), administration date: 07Aug2021, when the patient was 47 years old, for COVID-19 immunization, reaction(s): "numbness of whole body", "Burning sensation", "muscle pain", "neck issues", "spine issues", "neuropathic pain/ nerve pain", "vertigo", "full feeling in head", "dizzy", "vision trouble", "trouble with balance". The following information was reported: HYPOAESTHESIA (hospitalization), outcome "unknown", described as "numbness in whole body"; THROMBOCYTOPENIA (medically significant), EMBOLISM (medically significant), outcome "unknown" and all described as "thromboembolic events with thrombocytopenia"; VERTIGO (medically significant) with onset 15Jan2022, outcome "unknown", described as "Vertigo"; PAIN IN EXTREMITY (non-serious) with onset 15Oct2021, outcome "not recovered", described as "Severe hand pain"; BURNING SENSATION (non-serious) with onset 28Aug2021, outcome "unknown", described as "sevely burned"; PAIN (non-serious) with onset 28Aug2021, outcome "unknown", described as "Exvrutiating pain"; NEURALGIA (non-serious) with onset Sep2021, outcome "not recovered", described as "nerve pain/severe neuropathic pain - all of body burning in my nerves"; HEAD DISCOMFORT (non-serious), outcome "not recovered", described as "full feeling in head"; DIZZINESS (non-serious), outcome "not recovered", described as "dizzy"; VISUAL IMPAIRMENT (non-serious), outcome "not recovered", described as "vision trouble"; BALANCE DISORDER (non-serious), outcome "not recovered", described as "trouble with balance"; MYALGIA (non-serious), outcome "recovered", described as "overly sore muscles". The patient was hospitalized for hypoaesthesia (start date: 13Jan2022, discharge date: 16Jan2022, hospitalization duration: 3 day(s)). The event "vertigo" was evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: blood test: (05Oct2021) n/a; computerised tomogram head: (14Jan2022) n/a; magnetic resonance imaging head: (15Jan2022) vertigo; urine analysis: (13Jan2022) n/a. Therapeutic measures were taken as a result of vertigo, neuralgia. The clinical course was reported as follows: During vaccination injection it severely burned. From start to finish: excruciating pain. The patient wanted to stop the shot but didn't. About 1 week later patient experienced severe neuropathic pain - all of body burning in her nerves, full feeling in head, dizzy, vision trouble, trouble with balance, 5 months now. Was admitted to hospital 13Jan-16Jan this year for numbness of whole body. Diagnosed with vertigos treated with gabapentin for nerve pain. No relief then treated w/ Cymbalta: waiting for referral to neurologist. Will send results when receive them. Also overly sore muscles 4 months. None of specific relevant test for thromboembolic events with thrombocytopenia.   No follow-up attempts are possible. No further information is expected.